Kamada Remains Focused on Lung Treatment: CEO Tsur
Oct. 23 (Bloomberg) -- David Tsur, chief executive officer at Kamada, talks with Elliott Gotkine about what comes next for the company after a failed trial for an inhaled treatment for AAT. He speaks on “The Pulse.”
Most Recent Videos
Will Immigration Derail Merkel’s Reelection?
21:40 - Bloomberg’s Matt Miller discusses coming elections in Germany and the popularity of Angela Merkel. He speaks with Francine Lacqua on "Bloomberg Surveillance." (Source: Bloomberg)